CTi Biopharma Corp's activity chart (see below) currently has 51 price targets and 43 ratings on display.
Analysts' price targets on this stock were met 81.93% of the time, taking 475.76 days on average.
Most recent stock forecast was given by from JMP on 24-May-2023. First documented stock forecast 09-Sep-2014.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 24-May-2023
3 years 5 months 28 days ago
(24-May-2023)
4/4 (100%)
$4.25 (89.47%)
144
Buy Since 17-Oct-2022
$9.1
$13
3 years 6 months 5 days ago
(16-May-2023)
1/2 (50%)
$0.19 (2.13%)
36
Buy Since 06-May-2021
$9.1
$8.1
3 years 6 months 6 days ago
(15-May-2023)
5/5 (100%)
$0.17 (1.90%)
108
Buy Since 02-Dec-2021
$9
3 years 6 months 10 days ago
(11-May-2023)
7/7 (100%)
$3.88 (75.78%)
236
Buy Since 13-Oct-2020
$9.1
$8
3 years 6 months 11 days ago
(10-May-2023)
2/2 (100%)
$0.17 (1.90%)
491
What is CTIC (CTi Biopharma Corp) average time for price targets to be met?
Which analyst most recently updated their price target on CTIC (CTi Biopharma Corp)?
Which analyst has the most public recommendations on CTIC (CTi Biopharma Corp)?
Which analyst is the currently most bullish on CTIC (CTi Biopharma Corp)?
Which analyst is the currently most reserved on CTIC (CTi Biopharma Corp)?